These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9752347)

  • 1. [Update on cancerology of the upper aerodigestive tract].
    Demard F
    Bull Cancer; 1998 Jan; 85(1):48-9. PubMed ID: 9752347
    [No Abstract]   [Full Text] [Related]  

  • 2. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinomas of the larynx and hypopharynx. Curative treatment with preservation of laryngeal function.
    Million RR
    Front Radiat Ther Oncol; 1993; 27():31-40. PubMed ID: 8504950
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of hypopharyngeal cancer].
    Komiyama S; Masuda A; Tomita K; Kuratomi Y; Zingu K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2090-4. PubMed ID: 1716092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
    Snow GB
    Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
    [No Abstract]   [Full Text] [Related]  

  • 9. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
    Wolf GT
    Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In patients with cancer of the larynx, chemoradiotherapy with cisplatin is superior to neoadjuvant chemotherapy followed by radiotherapy and to exclusive radiotherapy].
    Racadot S; Mazeron JJ
    Bull Cancer; 2004 Mar; 91(3):211-2. PubMed ID: 15171045
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the role of primary surgery in the treatment of laryngeal and hypopharyngeal cancer? Hayes Martin Lecture.
    Lefebvre JL
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):285-8. PubMed ID: 10721998
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer.
    Major MS; Bumpous JM; Flynn MB; Schill K
    Laryngoscope; 2001 Aug; 111(8):1379-82. PubMed ID: 11568572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Borderline cases between the laryngeal and hypopharyngeal cancers].
    Miyahara H; Umatani K; Yoshino K; Sato T
    Gan No Rinsho; 1984 Sep; 30(11):1401-6. PubMed ID: 6502950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Locoregional recurrence of ORL cancer: the place of surgery].
    Julieron M; Temam S
    Bull Cancer; 2004 Nov; 91(11):863-9. PubMed ID: 15582890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding Keane et al.'s randomized trial comparing radiation alone to concomitant infusional 5-flurorouracil, bolus mitomycin-C and split-course radiation.
    Thomas C; Koh WJ
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):557. PubMed ID: 8276680
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in treatment of advanced head and neck carcinoma: review of the literature and report of a case.
    Rothman H
    J Am Osteopath Assoc; 1985 Jun; 85(6):370-4. PubMed ID: 4066434
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy--intergroup trial R91-11.
    Wolf GT
    J Clin Oncol; 2001 Sep; 19(18 Suppl):28S-31S. PubMed ID: 11560968
    [No Abstract]   [Full Text] [Related]  

  • 19. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locoregional recurrences of HNSCC: place of re-irradiations].
    Bourhis J; Temam S; Wibault P; Lusinchi A; de Crevoisier B; Janot R; Bobin S
    Bull Cancer; 2004 Nov; 91(11):871-3. PubMed ID: 15582891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.